drugset / Trial / NCT04325711
A Study of CSPCHA131 in Patients With Advanced Solid Tumor
NaSingle-groupOpen-labelTreatment
Summary
The study was designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of CSPCHA131 alone or plus chemotherapy in patients with advanced solid tumors.
Timeline
- Start
- 2020-04-24
- Primary completion
- 2021-04-12
- Completion
- 2021-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CSPCHA131 | Unknown | — | — |